Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer immunotherapy using dendritic cell-derived exosomes.

S Amigorena1

  • 1Unité INSERM U520, Institut Curie, Paris, France. sebastian.amigorena@curie.fr

Medicina
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.

Oncogene·2010
Same author

Induction of tolerance by exosomes and short-term immunosuppression in a fully MHC-mismatched rat cardiac allograft model.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Tumor-derived exosomes: a new source of tumor rejection antigens.

Vaccine·2002
Same author

FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.

Immunity·2002
Same author

Exosomes in cancer immunotherapy: preclinical data.

Advances in experimental medicine and biology·2002

Dendritic cell (DC)-derived exosomes, small vesicles, show potent anti-tumor effects. A single injection of tumor peptide-sensitized exosomes in mice eradicated established tumors by activating cytotoxic T lymphocytes.

Area of Science:

  • Immunology
  • Cell Biology
  • Nanotechnology

Background:

  • Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating cytotoxic immune responses.
  • DCs secrete exosomes, which are endocytic origin membrane vesicles (60-80 nm).

Purpose of the Study:

  • To systematically analyze the protein composition of DC-derived exosomes.
  • To investigate the in vivo immunomodulatory and anti-tumor potential of DC-derived exosomes.

Main Methods:

  • Proteomic analysis of exosome protein content.
  • In vivo administration of tumor peptide-sensitized exosomes in mice.
  • Assessment of anti-tumor immune responses, including T cell activation and tumor eradication.
  • In vivo CD8+ T cell depletion studies.

Related Experiment Videos

Main Results:

  • Exosomes contain MHC, co-stimulatory, and adhesion molecules, along with cytosolic factors.
  • DC-derived exosomes induced robust in vivo immune responses.
  • A single injection of tumor peptide-sensitized exosomes led to significant anti-tumor effects and eradicated established tumors in mice.
  • Tumor-specific cytotoxic T lymphocytes were detected in treated mice, and the anti-tumor effect was dependent on CD8+ T cells.

Conclusions:

  • DC-derived exosomes possess potent in vivo anti-tumor activity.
  • Exosomes can effectively prime anti-tumor immune responses, mediated by CD8+ T cells.
  • Human DC-derived exosomes represent a promising strategy for cancer immunotherapy.